ARCHIVES

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

This article is from The Cancer Letter archive.

Vol. 18 No. 29 | July 17, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Glick, Armitage Lead ASCO; NCAB Approves Resolution Calling For Higher NIH Budget

June 2, 1995

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

AHCPR Funds Centers to Review Practice

July 4, 1997

AACR Reschedules Annual Meeting For July 11-14, in Washington, DC

April 25, 2003

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

August 14, 1992